PE(14:0/22:5(4Z,7Z,10Z,13Z,16Z))
|
Basic information |
| Metabolite name | PE(14:0/22:5(4Z,7Z,10Z,13Z,16Z)) |
 | HMDB0008845 |
 |
C00350 |
 |
53479555 |
| Synonyms | NA |
| No. of studies | 1 |
|
Basic information |
| Metabolite name | PE(14:0/22:5(4Z,7Z,10Z,13Z,16Z)) |
| HMDB0008845 |
|
C00350 |
|
53479555 |
| Synonyms | NA |
| No. of studies | 1 |
|
Relationship between PE(14:0/22:5(4Z,7Z,10Z,13Z,16Z)) and depression (count: 1) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M949 | Type1 | ovariectomy group vs. control group | Serum | ICR mouse | Down |
| Study M949 | Type2 | ovariectomy + middle dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Up |
| Study M949 | Type2 | ovariectomy + high dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Up |
| Study M949 | Type2 | ovariectomy + low dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Up |
| Study M949 | Type2 | ovariectomy + fluoxetine group vs. ovariectomy group | Serum | ICR mouse | Up |